XML 33 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
Sep. 30, 2012
Dec. 31, 2011
Current assets:    
Cash and cash equivalents $ 282,293 $ 561,759
Short-term investment 39,215 39,110
Accounts receivable, net 335,117 143,320
Costs and estimated earnings in excess of billings on uncompleted contracts 8,107 66,454
Inventory 9,820   
Prepaid expenses and other current assets 1,405   
Total current assets 675,957 810,643
Equipment, net 6,680 8,058
Totals 682,637 818,701
Current liabilities:    
Accounts payable and accrued expenses 502,391 558,277
Accrued compensation and related costs    73,888
Accrued interest, related party 18,373 12,219
Related party accounts payable and accrued expenses 69,834 86,885
Related party notes payable 73,500 73,500
Billings in excess of costs and estimated earnings on uncompleted contracts 81,117   
Deferred revenue 120,900   
Warrant liabilities 183,377 198,471
Total current liabilities 1,049,492 1,003,240
Commitments      
Stockholders’ deficiency:    
Preferred stock, $0.01 par value, 5,000,000 shares authorized; 0 issued and outstanding at September 30, 2012 and December 31, 2011      
Common stock, $0.01 par value, 100,000,000 shares authorized; 41,985,950 issued and outstanding at September 30, 2012, 39,779,506 issued and outstanding at December 31, 2011 419,860 397,795
Common stock to be issued 14,000   
Additional paid-in capital 5,927,294 4,688,417
Accumulated deficiency (6,727,375) (5,270,751)
Accumulated other comprehensive loss (634)   
Total stockholders’ deficiency (366,855) (184,539)
Totals $ 682,637 $ 818,701